DrugPatentWatch Database Preview
AVASTIN Drug Profile
Summary for Tradename: AVASTIN
Patents: | 714 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 1 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for AVASTIN |
Pharmacology for AVASTIN
US Patents for AVASTIN
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | ➤ Sign Up | IMMATICS BIOTECHNOLOGY GMBH (Tuebingen, DE) | ➤ Sign Up | RX | search | |
Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | ➤ Sign Up | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (Seoul, KR) | ➤ Sign Up | RX | search | |
Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | ➤ Sign Up | IMMATICS BIOTECHNOLOGIES GMBH (Tuebingen, DE) | ➤ Sign Up | RX | search | |
Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | ➤ Sign Up | ➤ Sign Up | RX | search | ||
Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | ➤ Sign Up | TARIS Biomedical LLC (Lexington, MA) | ➤ Sign Up | RX | search | |
Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | ➤ Sign Up | ➤ Sign Up | RX | search | ||
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for AVASTIN
Country | Document Number | Estimated Expiration |
---|---|---|
Japan | 5992325 | ➤ Sign Up |
Argentina | 098647 | ➤ Sign Up |
Australia | 2016226264 | ➤ Sign Up |
Poland | 313907 | ➤ Sign Up |
World Intellectual Property Organization (WIPO) | 2006124413 | ➤ Sign Up |
Japan | 2014503535 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for AVASTIN
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
2014C/037 | Belgium | ➤ Sign Up | PRODUCT NAME: PACLITAXEL DANS UNE FORMULATION DE NANOPARTICULE LIEES A L'ALBUMINE; AUTHORISATION NUMBER AND DATE: EU/1/07/428 20131230 |
2006/025 | Ireland | ➤ Sign Up | PRODUCT NAME: NATALIZUMAB (ALSO KNOWN AS TYSABRI); REGISTRATION NO/DATE: EU/1/06/346/001 20060627 |
92780 | Luxembourg | ➤ Sign Up | PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826 |
122015000061 | Germany | ➤ Sign Up | PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826 |
300673 | Netherlands | ➤ Sign Up | PRODUCT NAME: PACLITAXEL, GEFORMULEERD ALS ALBUMINE-GEBONDEN NANODEELTJES; REGISTRATION NO/DATE: EU/1/07/428/001-002 20131220 |
23/2006 | Austria | ➤ Sign Up | PRODUCT NAME: NATALIZUMAB; REGISTRATION NO/DATE: EU/1/06/346/001 20060627 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |